Levosulpiride Injection
- Packing: 2 Ml Amp.
- Available Strength : 12.5 Mg/Ml
Description
Product Description:Our Levosulpiride Injection is a pharmaceutical formulation crafted to address various gastrointestinal and psychiatric disorders effectively. It contains levosulpiride, a selective dopamine D2 receptor antagonist, known for its prokinetic and antiemetic properties. Manufactured to the highest quality standards, this injection is trusted by healthcare professionals for its reliability and efficacy.
Indications and Usage:Levosulpiride Injection is indicated for the management of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), functional dyspepsia, irritable bowel syndrome (IBS), and diabetic gastroparesis. Additionally, it is used in the treatment of psychiatric conditions including schizophrenia and depression.
Dosage and Administration:The dosage of Levosulpiride Injection varies depending on the patient's condition, age, and severity of symptoms. It is administered via intravenous or intramuscular route under the supervision of a qualified healthcare professional. Dosage adjustments may be necessary based on the patient's response to therapy and tolerability.
Dosage Forms and Strengths:Levosulpiride Injection is available in vials containing a specific concentration of levosulpiride formulated for parenteral administration. Each vial is carefully manufactured to ensure accurate dosing and optimal therapeutic outcomes.
Contraindications:This product is contraindicated in patients with a known hypersensitivity to levosulpiride or any of the excipients. It should not be used in patients with a history of prolactin-dependent tumors or gastrointestinal obstruction.
Warnings and Precautions:Healthcare providers should exercise caution when prescribing Levosulpiride Injection to elderly patients or those with a history of cardiovascular diseases. Prolonged use may lead to extrapyramidal symptoms such as dystonia, parkinsonism, and tardive dyskinesia. Patients should be monitored closely for signs of these adverse effects during therapy.
Adverse Reactions/Side Effects:Common adverse reactions associated with Levosulpiride Injection include extrapyramidal symptoms, hyperprolactinemia, sedation, and gastrointestinal disturbances such as nausea and diarrhea. Rarely, allergic reactions such as rash or angioedema may occur.
Drug Interactions:Concomitant use of Levosulpiride Injection with other drugs that prolong the QT interval or inhibit CYP2D6 enzyme may increase the risk of cardiac arrhythmias. Healthcare providers should review the patient's medication profile carefully to avoid potential drug interactions.
Use In Specific Populations Description:Safety and efficacy of Levosulpiride Injection in pediatric patients, pregnant women, and nursing mothers have not been established conclusively. Healthcare providers should assess the potential risks and benefits before prescribing this medication in these populations.
How Supplied/Storage and Handling:Levosulpiride Injection is supplied as a sterile solution in vials for parenteral administration. It should be stored at controlled room temperature away from light and moisture. Care should be taken to avoid freezing or excessive heat exposure. Unused portions should be discarded according to standard procedures for biohazardous waste.
